康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06185 康希诺生物

已收盘 09-21 16:08:36

28.180

+1.820

+6.90%

最高28.320	最低26.360	成交量727.65万
今开26.360	昨收26.360	日振幅7.44%
总市值69.62亿	流通市值37.39亿	总股本2.47亿
成交额2.02亿	换手率5.48%	流通股本1.33亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06185","market":"HK","secType":"STK","nameCN":"康希诺生物","latestPrice":28.18,"timestamp":1789978116008,"preClose":26.36,"halted":0,"volume":7276499,"delay":0,"changeRate":0.06904400606980274,"floatShares":132670900,"shares":247043801,"eps":0.12893257280944012,"marketStatus":"已收盘","change":1.82,"latestTime":"09-21 16:08:36","open":26.36,"high":28.32,"low":26.36,"amount":201716224,"amplitude":0.074355,"askPrice":28.22,"askSize":7000,"bidPrice":28.18,"bidSize":1600,"shortable":3,"etf":0,"ttmEps":0.19280576937923674,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790040600000},"marketStatusCode":5,"adr":0,"listingDate":1553702400000,"exchange":"SEHK","adjPreClose":26.36,"openAndCloseTimeList":[[1789954200000,1789963200000],[1789966800000,1789977600000]],"volumeRatio":1.885926,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688185","market":"SH","secType":"STK","nameCN":"康希诺","latestPrice":72.46,"timestamp":1789974000000,"preClose":68.05,"halted":0,"volume":11280300,"delay":0,"premium":"-66.82"}},"requestUrl":"/m/hq/s/06185","defaultTab":"news","newsList":[{"id":"1113602754","title":"异动解读｜康希诺生物盘中上涨5.08%，生物科技板块走强叠加mRNA肿瘤疫苗主题催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1113602754","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113602754?lang=zh_cn&edition=full","pubTime":"2026-09-21 10:03","pubTimestamp":1789956230,"startTime":"0","endTime":"0","summary":"9月21日，康希诺生物盘中上涨5.08%，报27.72港元/股，成交额6046.05万港元。消息面上，近期券商研报指出mRNA癌症疫苗是mRNA技术市场价值跃升的核心路径，Moderna个性化mRNA癌症疫苗三期临床达到主要终点，属平台级别的估值重估。康希诺生物此前已与德普世生物签署mRNA个性化治疗型肿瘤疫苗合作框架协议，其递送技术平台价值进一步凸显。同日生物科技板块整体走强，康方生物涨8.45%，信达生物涨6.31%，科伦博泰生物涨6.07%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物上涨，mRNA肿瘤疫苗催化","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141561079","title":"异动解读｜康希诺生物盘中上涨6.86%，中期业绩扭亏叠加股权激励落地提振市场情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1141561079","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141561079?lang=zh_cn&edition=full","pubTime":"2026-09-18 09:38","pubTimestamp":1789695488,"startTime":"0","endTime":"0","summary":"9月18日，康希诺生物盘中上涨6.86%，报27.2港元/股，成交额3899.3万港元。消息面上，公司最新披露的中期业绩显示，上半年营收约5.47亿元，同比增长46.1%；经营利润约2753.70万元，实现扭亏为盈；经调整净亏损仅72.10万元，较上年同期亏损1348.5万元大幅收窄。海外收入1.52亿元，同比暴增4724.19%，国际化业务加速兑现。此外，公司于9月16日向19名激励对象授出合计28.74万股限制性股票，授予价格为每股41.20元人民币，释放管理层对公司发展的信心信号。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物盘中上涨，中期业绩扭亏为盈","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178581435","title":"康希诺生物2026年中期营收5.47亿元，经调整净亏损72.10万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1178581435","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178581435?lang=zh_cn&edition=full","pubTime":"2026-09-17 16:39","pubTimestamp":1789634343,"startTime":"0","endTime":"0","summary":"康希诺生物公布的2026年中期报告显示，期内营收约5.47亿元，同比增长46.1%。期内经调整净亏损72.10万元，相比去年同期的亏损1,348.5万元，亏损明显收窄。期内经营利润约2,753.70万元，较上年同期的经营亏损220.80万元实现扭亏为盈。经营性现金流净额则由去年同期的342.40万元流入转为约1.20亿元流出。报告期内，毛利约4.13亿元，同比上涨39.4%，对应毛利率为75.6%。相较去年同期79.3%的毛利率有所下降，但仍保持在较高水平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"康希诺生物2026年中期营收5.47亿元，经调整净亏损72.10万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158206584","title":"异动解读｜康希诺生物盘中上涨5.13%，股权激励预留授予落地叠加生物科技板块走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1158206584","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158206584?lang=zh_cn&edition=full","pubTime":"2026-09-17 10:29","pubTimestamp":1789612191,"startTime":"0","endTime":"0","summary":"9月17日，康希诺生物盘中上涨5.13%，报26.64港元/股，成交额7729.57万港元。消息面上，公司9月16日公告，依据2025年A股限制性股票激励计划，向19名符合条件的激励对象授出合计28.74万股限制性股票，授予价格为每股41.20元人民币，占总股本0.1163%。预留授予落地释放管理层对公司发展的信心信号。基本面上，公司上半年营收5.50亿元，同比增长43.81%，归母净亏损大幅收窄至72.08万元，海外收入同比暴增4724.19%，国际化业务加速兑现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物上涨，股权激励落地释放信心","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198377509","title":"康希诺生物（06185）向19名员工授出28.74万股A股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1198377509","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198377509?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:55","pubTimestamp":1789552521,"startTime":"0","endTime":"0","summary":"2026年9月16日，康希诺生物股份公司公告，根据2025年A股激励计划的预留授予安排，董事会已于同日向19名符合条件的激励对象授出合计287,400股限制性股票，授予价格为每股人民币41.20元。该批限制性股票占公司目前总股本的0.1163%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132551258","title":"康希诺生物（06185）向19名员工授予28.74万股预留限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1132551258","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132551258?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:52","pubTimestamp":1789552346,"startTime":"0","endTime":"0","summary":"2026年9月16日，康希诺生物股份公司董事会通过决议，依据《2025年A股限制性股票激励计划》，向符合条件的19名激励对象授予部分预留限制性股票。公司董事会及薪酬与考核委员会确认，授予条件已满足，全部激励对象符合《上市公司股权激励管理办法》等相关规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667046996","title":"康希诺生物(06185)授出合共28.74万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2667046996","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667046996?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:48","pubTimestamp":1789552126,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康希诺生物(06185)发布公告，董事会议决于2026年9月16日(预留授予日)，按每股A股人民币41.20元的授予价格，根据2025年A股激励计划的预留授予(预留授予)，向19名符合授予条件的激励对象授出合共28.74万股限制性股票。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1191","BK1161","BK1574","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125579251","title":"异动解读｜康希诺生物盘中上涨5.12%，生物科技板块整体走强叠加业绩说明会临近","url":"https://stock-news.laohu8.com/highlight/detail?id=1125579251","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125579251?lang=zh_cn&edition=full","pubTime":"2026-09-14 10:34","pubTimestamp":1789353240,"startTime":"0","endTime":"0","summary":"9月14日，康希诺生物盘中上涨5.12%，报27.12港元/股，成交额4646.9万港元。生物科技板块整体走强，康方生物涨5.32%，云顶新耀涨4.25%，百济神州涨1.75%。消息面上，公司将于9月15日参加科创板半年度生物制品及CXO行业集体业绩说明会，届时就经营及财务情况与投资者交流。此前公司披露的中报显示，上半年营业收入5.50亿元，同比增长43.81%；海外收入1.52亿元，同比暴增4724.19%；归母净亏损大幅收窄至72.08万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"生物科技板块走强，康希诺生物盘中上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198951735","title":"异动解读｜康希诺生物盘中下跌5.51%，报25.36港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1198951735","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198951735?lang=zh_cn&edition=full","pubTime":"2026-09-11 10:17","pubTimestamp":1789093062,"startTime":"0","endTime":"0","summary":"9月11日，康希诺生物盘中下跌5.51%，报25.36港元/股，成交额3547.99万港元。康希诺生物所在的生物科技行业中，板块整体走弱，个股中，信达生物跌2.38%，康方生物跌2.67%，百济神州跌1.64%，剂泰科技-P跌10.52%，云顶新耀跌5.18%。康希诺生物股份公司是一家处于临床阶段的中国疫苗公司，产品包括埃博拉病毒疫苗、脑膜炎球菌疫苗、肺炎球菌疫苗及重组新型冠状病毒疫苗等，主要应用于脑膜炎、百白破和肺炎领域。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143882347","title":"异动解读｜康希诺生物盘中下跌5.09%，报27.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143882347","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143882347?lang=zh_cn&edition=full","pubTime":"2026-09-10 10:19","pubTimestamp":1789006790,"startTime":"0","endTime":"0","summary":"9月10日，康希诺生物盘中下跌5.09%，报27.2港元/股，成交额3886.0万港元。康希诺生物所在的生物科技行业中，板块整体走弱，个股中，信达生物跌2.49%，康方生物跌0.79%，三生制药跌3.16%，百济神州跌0.67%，云顶新耀跌7.82%。康希诺生物股份公司是一家处于临床阶段的中国疫苗公司，产品包括埃博拉病毒疫苗、脑膜炎球菌疫苗、肺炎球菌疫苗及重组新型冠状病毒疫苗等，主要应用于脑膜炎、百白破和肺炎领域。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666128556","title":"【券商聚焦】中信证券：中国创新药进入全球价值兑现阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2666128556","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666128556?lang=zh_cn&edition=full","pubTime":"2026-09-10 08:59","pubTimestamp":1789001960,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指，2026年以来，中国创新药国内市场快速放量，从中报来看头部创新药企业在新产品驱动下，创新药收入快速增长，biopharma陆续进入盈利拐点；出海创新药开始进入三期/注册研究兑现阶段；近期多个国际学术大会将至，众多创新药管线进入密集的数据催化期。该机构认为中国创新药进入全球价值兑现阶段，建议关注：①头部国际化创新药企业有望迎来产品全球价值兑现期；②头部创新药企业产品放量进入新的成长阶段；③具有全球潜力的管线资产国际化有望加速兑现。综上，我们维持创新药行业“强于大市”评级。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1991210","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","LU0405327494.USD","LU0572944931.SGD","BK0028","LU1255011170.USD","LU1969619763.USD","06030","LU0348783233.USD","LU1226287792.SGD","LU1813983027.USD","09995","IE00B543WZ88.USD","LU1655091616.SGD","02269","BK1141","09688","SG9999004220.SGD","LU0819121731.USD","LU2148510915.USD","LU1064130708.USD","01093","600030","KCE","01177","LU1226287875.USD","01877","LU1880383366.USD","LU1580142542.USD","LU1794554557.SGD","LU0348825331.USD","LU1720050803.USD","LU2580892862.HKD","LU0516422952.EUR","LU2039709279.SGD","06160","06185","LU1997245177.USD","02616","LU1820825898.SGD","LU0561508036.HKD","02142","LU0979878070.USD","BK1161","LU0417516738.SGD","LU0181495838.USD","IE0008369823.USD","LU1961090484.USD","09926","01801","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113703587","title":"港股生物医药股午后走强，剂泰科技-P涨近15%，百奥赛图-B、金斯瑞生物科技涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113703587","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113703587?lang=zh_cn&edition=full","pubTime":"2026-09-08 13:33","pubTimestamp":1788845625,"startTime":"0","endTime":"0","summary":"9月8日，港股$生物(000504)$医药股午后走强，$剂泰科技-P(07666)$涨近15%，$百奥赛图-B(02315)$、$金斯瑞生物科技(01548)$涨近10%，$泰格医药(03347)$、$康希诺生物(06185)$、$云顶新耀(01952)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK4588","02315","HK0000306685.HKD","07666","BK4581","09939","BK1574","399441","BK1583","01548","01952","HK0000320223.HKD","BK4585","HK0000306701.USD","03347","HK0000320264.USD","KCAI","BK1161","XBI","BK1191","161726","BK0216","688796","BK1141","VXUS","06185","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182523066","title":"异动解读｜康希诺生物盘中上涨5.47%，中报业绩亮眼叠加mRNA肿瘤疫苗赛道催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1182523066","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1182523066?lang=zh_cn&edition=full","pubTime":"2026-09-08 13:29","pubTimestamp":1788845380,"startTime":"0","endTime":"0","summary":"9月8日，康希诺生物盘中上涨5.47%，报30.06港元，成交额1.38亿港元。消息面上，公司此前披露半年报显示，上半年实现营收5.50亿元，同比增长43.81%；归母净亏损同比收窄94.65%至72.08万元；海外收入达1.52亿元，同比增长4724.19%，国际化从布局加速走向兑现。此外，公司近期与德普世生物签署mRNA个性化治疗型肿瘤疫苗合作框架协议，里昂指出其开发路线及抗原设计与Moderna大致相若，叠加全球首个mRNA肿瘤疫苗三期临床成功，平台级估值修复逻辑持续发酵。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物上涨，肿瘤疫苗催化","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122634913","title":"康希诺生物（06185）将于9月15日参加科创板半年度生物制品及CXO行业集体业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1122634913","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122634913?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:52","pubTimestamp":1788511970,"startTime":"0","endTime":"0","summary":"康希诺生物股份公司9月4日在香港联交所披露海外监管公告称，公司将参加“科创板2026年半年度生物制品及CXO行业集体业绩说明会”，并就投资者关心的经营及财务情况进行交流。公司已于2026年8月28日发布2026年半年度报告，说明会将围绕上半年经营成果及财务指标答复投资者普遍关注的问题。说明会结束后，投资者可通过上证路演中心查看会议记录及主要内容。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156353265","title":"康希诺生物8月股份变动月报：股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1156353265","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156353265?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:38","pubTimestamp":1788424723,"startTime":"0","endTime":"0","summary":"康希诺生物股份公司于2026年9月3日发布2026年8月31日止月份的证券变动月报表，披露报告期内公司已发行股份及注册股本未发生增减变动。报告期内，未发生新增发行、回购、注销或库藏股的活动，已发行股份总数及库存股份数量均维持不变。公司此前通过的2025年核心管理层H股购股权计划共授出860,000份H股购股权，截至2026年8月31日，相关购股权数量无变动，报告期内未有新股因行使期权而发行。截至本月末，康希诺生物股本结构保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814735","title":"康希诺生物上半年海外收入同比增长4724.19% 体系化“出海”打开增长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814735","media":"证券日报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664814735?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:31","pubTimestamp":1788352260,"startTime":"0","endTime":"0","summary":"上半年公司实现营业收入5.5亿元，同比增长43.81%；归母净亏损同比大幅收窄。最亮眼的变化来自国际化业务：海外收入1.52亿元，同比增长4724.19%。第二条路，也是本次收入爆发的核心推手：技术与产业化能力“出海”。康希诺生物跑出一套复合模式：成品疫苗销售、疫苗中间品供应、工艺技术转移、海外联合临床开发四线并行。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-02/doc-iniqmwqs1387320.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-09-02/doc-iniqmwqs1387320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1191","BK1574","BK1161","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664892928","title":"智通AH统计|9月2日","url":"https://stock-news.laohu8.com/highlight/detail?id=2664892928","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664892928?lang=zh_cn&edition=full","pubTime":"2026-09-02 16:15","pubTimestamp":1788336906,"startTime":"0","endTime":"0","summary":"东北电气0.2432.251011.11%-9.29%浙江世宝4.03517.05406.07%50.65%弘业期货2.2508.16334.22%23.89%中石化油服0.6602.23304.55%-5.17%晨鸣纸业0.5951.92286.55%29.01%复旦张江2.5158.06283.70%5.24%凯盛新能2.2657.21281.46%28.57%南京熊猫电子股份3.27010266.36%21.77%安德利果汁21.74066.08264.08%-10.48%京城机电股份2.8208.51261.35%26.19%. 宁德时代564.500360.28-23.55%2.52%招商银行51.75040.87-5.41%-0.95%药明康德193.700155.99-3.54%0.63%兆易创新472.200388.86-1.36%-0.23%中际旭创996.000830.33-0.14%-1.53%潍柴动力30.30026.293.93%1.04%美的集团99.95086.984.23%-0.97%立讯精密63.60057.087.50%-6.73%交通银行7.9307.4312.23%-1.61%紫金矿业35.80033.7312.85%-1.18%. 备注：以上数据由智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490892.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03678","00568","01057","00553","00668","02846","83188","00042","01055","02475","03968","03308","01349","03143","06869","03130","01877","02359","IE0034224299.USD","03750","01033","06613","02701","06826","00187","02338","82846","03296","399300","LU0890818403.SGD","00981","03986","03328","01812","LU0039217434.USD","00991","07233","01108","00300","02899","EWH","02218","02827","06185","159982","03188","83130","06821","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167630418","title":"异动解读｜康希诺生物盘中上涨7.93%，里昂维持跑赢大市评级叠加前期回调后资金回补","url":"https://stock-news.laohu8.com/highlight/detail?id=1167630418","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1167630418?lang=zh_cn&edition=full","pubTime":"2026-09-02 09:35","pubTimestamp":1788312933,"startTime":"0","endTime":"0","summary":"9月2日，康希诺生物盘中上涨7.93%，报31.76港元，成交额6898.44万港元。消息面上，里昂最新研报维持公司\"跑赢大市\"评级，目标价49.6港元，较当前股价仍有约56%上行空间，并上调公司净利预测至1.21亿元、3.23亿元及7.23亿元人民币，看好其破伤风疫苗获批后的销售增长动力。此前公司披露中期业绩，上半年营收5.50亿元，同比增长43.81%，净亏损72.08万元，同比收窄94.65%，海外收入约1.52亿元实现大幅增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康希诺生物异动拉升，里昂看多催化反弹","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664725887","title":"里昂：下调康希诺生物(06185.HK)目标价至49.6港元 维持“跑赢大市”","url":"https://stock-news.laohu8.com/highlight/detail?id=2664725887","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664725887?lang=zh_cn&edition=full","pubTime":"2026-09-01 11:18","pubTimestamp":1788232700,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1515","BK1191","BK1574","BK1161","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663073923","title":"智通AH统计|8月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=2663073923","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663073923?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:15","pubTimestamp":1788164105,"startTime":"0","endTime":"0","summary":"东北电气0.2422.251015.70%2.16%浙江世宝3.96016.58401.52%51.14%弘业期货2.2407.91322.77%14.23%中石化油服0.6602.29315.15%6.17%复旦张江2.5208.09284.52%6.86%晨鸣纸业0.6101.91275.41%18.37%凯盛新能2.2957.18274.73%24.65%安德利果汁22.20067.75265.54%-13.04%南京熊猫电子股份3.3159.73251.43%9.64%京城机电股份2.8508.29248.42%16.04%. 康希诺生物29.50085.36246.58%74.87%浙江世宝3.96016.58401.52%51.14%山东墨龙4.7008.45115.32%30.05%凯盛新能2.2957.18274.73%24.65%晨鸣纸业0.6101.91275.41%18.37%上海电气2.9106.58170.79%17.02%京城机电股份2.8508.29248.42%16.04%沃尔核材10.07017.12103.67%14.52%中国国航3.7705.9488.59%14.33%丽珠医药19.88026.4759.51%14.26%. 备注：以上数据由智通机器人根据港交所数据，经过人工智能运算后自动生成，并不保证数据100%准确；偏离值为当前溢价率与该股过去30天平均溢价率的差值。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01033","03200","03143","03296","LU0327786744.USD","03268","06185","03968","01513","02846","159982","03750","02475","00981","03188","EWH","01877","00187","06869","03308","83130","82846","01349","02827","00568","02218","00553","399300","02691","00991","03130","00300","83188","01057","01108","02338","02727","06690","03986","07233","03678","01812","03328","00042","09981","02359","00753","LU0348816934.USD","00317"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cansinotech.com","stockEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":0.1294},{"period":"3month","weight":0.1747},{"period":"6month","weight":-0.2051},{"period":"1year","weight":-0.4989},{"period":"ytd","weight":-0.2451}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":-0.0292},{"period":"3month","weight":0.0345},{"period":"6month","weight":-0.0208},{"period":"1year","weight":-0.0676},{"period":"ytd","weight":-0.0343}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.030578},{"month":2,"riseRate":0.857143,"avgChangeRate":0.172684},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.060436},{"month":4,"riseRate":0.625,"avgChangeRate":0.049828},{"month":5,"riseRate":0.25,"avgChangeRate":-0.051769},{"month":6,"riseRate":0.5,"avgChangeRate":0.015607},{"month":7,"riseRate":0.625,"avgChangeRate":0.054796},{"month":8,"riseRate":0.25,"avgChangeRate":-0.091996},{"month":9,"riseRate":0.625,"avgChangeRate":0.04648},{"month":10,"riseRate":0.428571,"avgChangeRate":0.059174},{"month":11,"riseRate":0.571429,"avgChangeRate":0.088604},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.035813}],"exchange":"SEHK","name":"康希诺生物","nameEN":"CANSINOBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康希诺生物,06185,康希诺生物股票,康希诺生物股票老虎,康希诺生物股票老虎国际,康希诺生物行情,康希诺生物股票行情,康希诺生物股价,康希诺生物股市,康希诺生物股票价格,康希诺生物股票交易,康希诺生物股票购买,康希诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康希诺生物(06185)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康希诺生物(06185)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}